8
views
0
recommends
+1 Recommend
0 collections
    1
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The role of AP-1 in glucocorticoid resistance in leukaemia.

      Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K
      Adult, Base Sequence, Blotting, Northern, Blotting, Western, Child, Preschool, DNA Primers, Drug Resistance, Neoplasm, Female, Glucocorticoids, pharmacology, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, metabolism, pathology, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Proto-Oncogene Proteins c-fos, Proto-Oncogene Proteins c-jun, Transcription Factor AP-1, physiology

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glucocorticoids are used in the treatment of acute lymphoblastic leukaemia (ALL) and chronic lymphocytic leukaemia (CLL) but many patients develop glucocorticoid resistance on relapse. The ligand-activated glucocorticoid receptor inhibits activity of the AP-1 transcription factor and the purpose of this study was to test the hypothesis that up-regulation or overexpression of AP1-binding activity may be an important mechanism of glucocorticoid resistance in ALL and CLL. In vitro sensitivity of patient blasts to prednisolone was measured using th

          Related collections

          Author and article information

          Comments

          Comment on this article